CALCConference•prnewswire•
CalciMedica to Participate in the H.C. Wainwright 27th Annual Global Investment Conference
Sentiment:Negative (20)
Summary
(NASDAQ:CALC) LA JOLLA, Calif., Sept. 2, 2025 /PRNewswire/ -- CalciMedica Inc. ("CalciMedica" or the "Company") (Nasdaq: CALC), a clinical-stage biopharmaceutical company focused on developing novel calcium release-activated calcium (CRAC) channel inhibition therapies for acute and chronic inflammatory...
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on September 2, 2025 by prnewswire